Challenges for intraventricular hemorrhage research and emerging therapeutic targets
- 30 October 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 21 (12) , 1111-1122
Abstract
Introduction: Intraventricular hemorrhage (IVH) affects both premature infants and adults. In both demographics, it has high mortality and morbidity. There is no FDA approved therapy that improves neurological outcome in either population highlighting the need for additional focus on therapeutic targets and treatments emerging from preclinical studies. Areas covered: IVH induces both initial injury linked to the physical effects of the blood (mass effect) and secondary injury linked to the brain response to the hemorrhage. Preclinical studies have identified multiple secondary injury mechanisms following IVH, and particularly the role of blood components (e.g. hemoglobin, iron, thrombin). This review, with an emphasis on pre-clinical IVH research, highlights therapeutic targets and treatments that may be of use in prevention, acute care, or repair of damage. Expert opinion: An IVH is a potentially devastating event. Progress has been made in elucidating injury mechanisms, but this has still to translate to the clinic. Some pathways involved in injury also have beneficial effects (coagulation cascade/inflammation). A greater understanding of the downstream pathways involved in those pathways may allow therapeutic development. Iron chelation (deferoxamine) is in clinical trial for intracerebral hemorrhage and preclinical data suggest it may be a potential treatment for IVH.Keywords
Funding Information
- National Institutes of Health (NS073595)
This publication has 130 references indexed in Scilit:
- The intrathecal CD163‐haptoglobin–hemoglobin scavenging system in subarachnoid hemorrhageJournal of Neurochemistry, 2012
- Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammationNature Communications, 2012
- Inhibition of Carbonic Anhydrase Reduces Brain Injury After Intracerebral HemorrhageTranslational Stroke Research, 2011
- A Novel Preclinical Model of Germinal Matrix Hemorrhage Using Neonatal Rats2011
- Inflammation of the Choroid Plexus and Ependymal Layer of the Ventricle Following Intraventricular HemorrhageTranslational Stroke Research, 2011
- Iron Toxicity in Mice with Collagenase-Induced Intracerebral HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2010
- Blood–brain barrier breakdown and repair by Src after thrombin‐induced injuryAnnals of Neurology, 2010
- Minocycline attenuates iron neurotoxicity in cortical cell culturesBiochemical and Biophysical Research Communications, 2009
- Inhibition of Aquaporin-1 and Aquaporin-4 Water Permeability by a Derivative of the Loop Diuretic Bumetanide Acting at an Internal Pore-Occluding Binding SiteMolecular Pharmacology, 2009
- Intracerebral haemorrhageThe Lancet, 2009